Pfizer, partner BioNTech say updated COVID shot shows better immune response

Pfizer and partner BioNTech said on Monday their updated COVID-19 vaccine showed an increased immune response in adults aged 65 and older as well as those aged 18 through 64 with at least one underlying risk condition. ...